Table 2 Association between the clonal status of BCL9L mutation and clinical feartures in colorectal cancer
| Â | Clonal | Subclonal | WT | P-value |
|---|---|---|---|---|
Age | ||||
 < 67.5(median) | 19 | 6 | 241 | 0.19 |
  >  = 67.5(median) | 19 | 1 | 248 |  |
Sex | ||||
 Female | 17 | 3 | 237 | 0.89 |
 Male | 21 | 4 | 252 |  |
MSI status | ||||
 MSI | 30 | 5 | 121 |  < 0.001* |
 MSS | 8 | 2 | 366 |  |
Tumour site | ||||
 Right-sided | 25 | 3 | 191 | 0.004* |
 Left-sided | 12 | 4 | 281 |  |
AJCC stage | ||||
 Stage 1/Stage 2 | 30 | 6 | 253 |  < 0.001* |
 Stage 3/Stage 4 | 7 | 0 | 219 |  |
N stage | ||||
 N0 | 30 | 7 | 269 |  < 0.001* |
 N1/N2 | 8 | 0 | 218 |  |
T stage | ||||
 T1/T2 | 6 | 3 | 104 | 0.26 |
 T3/T4 | 32 | 4 | 383 |  |
M stage | ||||
 M0 | 31 | 5 | 356 | 0.012* |
 M1 | 0 | 0 | 72 |  |